Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-13-332838

← back to feed
Filed
Aug 13, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Aug 13, 2013 24.81M sh
Capex Q2 2013 · Jun 30, 2013 $429.83K
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$16.9M
Stockholders Equity Q2 2013 · Jun 30, 2013 −$890.29K
Stockholders Equity Q2 2013 · Dec 31, 2012 $4.99K
Current Liabilities Q2 2013 · Jun 30, 2013 $1.29M
Current Liabilities Q2 2013 · Dec 31, 2012 $1.3M
Current Assets Q2 2013 · Jun 30, 2013 $362.4K
Current Assets Q2 2013 · Dec 31, 2012 $1.28M
Total Assets Q2 2013 · Jun 30, 2013 $400.92K
Total Assets Q2 2013 · Dec 31, 2012 $1.31M
Sga Expense Q2 2013 · Jun 30, 2013 $9.87M
Rd Expense Q2 2013 · Jun 30, 2013 $11.24M
Net Income Q2 2013 · Jun 30, 2013 −$21.5M
Operating Income Q2 2013 · Jun 30, 2013 −$19.73M
Revenue Q2 2013 · Jun 30, 2013 $1.39M
Cash And Equivalents Q2 2013 · Mar 28, 2002 $0